New England Asset Management’s Core Laboratories CLB Stock Holding History

New England Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,782	Closed	-$670K	–	181
2018 Q3	$670K	Hold	5,782	–	–	0.01%	119
2018 Q2	$730K	Buy	+5,782	New	+$704K	0.01%	109

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

New England Asset Management's CLB Position: Q4 2018 in Review

New England Asset Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 5,782 shares — an estimated $670K sold.

New England Asset Management first reported a position in CLB in Q2 2018 and held it in 2 quarters. The position peaked at $730K in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

New England Asset Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
New England Asset Management sold 5,782 Core Laboratories shares in Q4 2018, an estimated $670K.
New England Asset Management first reported a position in Core Laboratories in Q2 2018 and held it in 2 quarters.
New England Asset Management's Core Laboratories position peaked at $730K in Q2 2018.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on New England Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.